UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock

The New England journal of medicine, 1999-08, Vol.341 (9), p.625-634

1999

Volltextzugriff (PDF)

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

The New England journal of medicine, 1995-02, Vol.332 (8), p.481-487

1995

Volltextzugriff (PDF)

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

The New England journal of medicine, 1999-07, Vol.341 (5), p.319-327

1999

Volltextzugriff (PDF)

Combined accelerated tissue-plasminogen activator and Platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute Myocardial Infarction : Results of a randomized, placebo-controlled, dose-ranging trial

Circulation (New York, N.Y.), 1997-02, Vol.95 (4), p.846-854

1997

Volltextzugriff (PDF)

Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction

Circulation (New York, N.Y.), 1994-11, Vol.90 (5), p.2280-2284

1994

Volltextzugriff (PDF)

Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study)

The American journal of cardiology, 2001-11, Vol.88 (10), p.1097-1102

2001

Volltextzugriff (PDF)

Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME Multicenter Registry: Comparison With the randomized clinical trial

Journal of the American College of Cardiology, 2002-01, Vol.39 (2), p.266-273

2002

Volltextzugriff (PDF)

Two-dimensional and Doppler transesophageal echocardiographic delineation and flow characterization of anomalous coronary arteries in adults

Journal of the American Society of Echocardiography, 2003-12, Vol.16 (12), p.1274-1286

2003

Volltextzugriff (PDF)

Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty

Circulation (New York, N.Y.), 1996-08, Vol.94 (4), p.629-635

1996

Volltextzugriff (PDF)

Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial)

The American journal of cardiology, 2002-09, Vol.90 (6), p.585-590

2002

Volltextzugriff (PDF)

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention : Results of the gold (AU-assessing ultegra) multicenter study

Circulation (New York, N.Y.), 2001-05, Vol.103 (21), p.2572-2578

2001

Volltextzugriff (PDF)

Relation of coronary artery size to one-year clinical events after new device angioplasty of native coronary arteries (a New Approach to Coronary Intervention [NACI] Registry report)

The American journal of cardiology, 2000-01, Vol.85 (2), p.166-171

2000

Volltextzugriff (PDF)

Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry

Journal of the American College of Cardiology, 2000-09, Vol.36 (3), p.1110-1116

2000

Volltextzugriff (PDF)

Intravenous fluosol in the treatment of acute myocardial infarction : results of the thrombolysis and angioplasty in myocardial infarction 9 trial

Circulation (New York, N.Y.), 1994-07, Vol.90 (1), p.114-120

1994

Volltextzugriff (PDF)

Pharmacology of GP IIb-IIIa Platelet Inhibitors, Part IV

Journal of interventional cardiology, 2000-08, Vol.13 (4), p.243-254

TALLEY, J. DAVID

2000

Volltextzugriff (PDF)

Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute Myocardial Infarction

Journal of thrombosis and thrombolysis, 2000, Vol.9 (1), p.5-12

2000

Volltextzugriff (PDF)

Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry

The American heart journal, 2001-06, Vol.141 (6), p.964-970

2001

Volltextzugriff (PDF)

Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: Insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences

The American heart journal, 2000-06, Vol.139 (6), p.1046-1053

2000

Volltextzugriff (PDF)

Economic Implications of the Prophylactic Use of Intraaortic Balloon Counterpulsation in the Setting of Acute Myocardial Infarction

The American journal of cardiology, 1997-03, Vol.79 (5), p.590-594

1997

Volltextzugriff (PDF)

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty

Circulation (New York, N.Y.), 1994-10, Vol.90 (4), p.1757-1764

1994

Volltextzugriff (PDF)

Economic and angiographic factors in determining optimal catheter size in performing outpatient left-sided heart and coronary angiography

The American journal of cardiology, 1996-02, Vol.77 (5), p.374-378

1996

Volltextzugriff (PDF)

Cost and therapeutic modification of intracoronary ultrasound-assisted coronary angioplasty

The American journal of cardiology, 1996-06, Vol.77 (15), p.1278-1282

1996

Volltextzugriff (PDF)

Surgical complications from hemostatic puncture closure devices

The American journal of surgery, 1999-12, Vol.178 (6), p.511-515

1999

Volltextzugriff (PDF)

Current spectrum of cardiogenic shock and effect of early revascularization on mortality : results of an international registry

Circulation (New York, N.Y.), 1995-02, Vol.91 (3), p.873-881

1995

Volltextzugriff (PDF)

Progress in Interventional Cardiology

Journal of interventional cardiology, 1999-06, Vol.12 (3), p.227-230

1999

Volltextzugriff (PDF)

1 – 25 von 389

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(292)
Mit Volltextzugriff
(346)

Publikationsform

Sprache

Englisch
(387)
Japanisch
(41)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

Combined accelerated tissue-plasminogen activator and Platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute Myocardial Infarction : Results of a randomized, placebo-controlled, dose-ranging trial

Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction

Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study)

Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME Multicenter Registry: Comparison With the randomized clinical trial

Two-dimensional and Doppler transesophageal echocardiographic delineation and flow characterization of anomalous coronary arteries in adults

Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty

Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial)

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention : Results of the gold (AU-assessing ultegra) multicenter study

Relation of coronary artery size to one-year clinical events after new device angioplasty of native coronary arteries (a New Approach to Coronary Intervention [NACI] Registry report)

Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry

Intravenous fluosol in the treatment of acute myocardial infarction : results of the thrombolysis and angioplasty in myocardial infarction 9 trial

Pharmacology of GP IIb-IIIa Platelet Inhibitors, Part IV

Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute Myocardial Infarction

Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry

Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: Insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences

Economic Implications of the Prophylactic Use of Intraaortic Balloon Counterpulsation in the Setting of Acute Myocardial Infarction

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty

Economic and angiographic factors in determining optimal catheter size in performing outpatient left-sided heart and coronary angiography

Cost and therapeutic modification of intracoronary ultrasound-assisted coronary angioplasty

Surgical complications from hemostatic puncture closure devices

Current spectrum of cardiogenic shock and effect of early revascularization on mortality : results of an international registry

Progress in Interventional Cardiology

Suchergebnisse filtern